89Zr-HuMab-5B1

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name89Zr-HuMab-5B1
Drug Alias Nameanti-sialyl Lewisa imaging agent (MabVax)radiolabelled 5B1 diabodyradiolabelled anti-CA 19.9 antibodyradiolabelled 5B1 antibodyradiolabeled HuMab 5B1 antibody +[10] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersIonising radiation emittersDiagnostic imaging enhancers +[4] 
TargetsCA19.9(Carbohydrate antigen 19-9)
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiontech Se
Inactive CompaniesBiontech Research & Development Inc
Active IndicationsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A